AAA December 2015 – Page 10

GSK stars in $55m Constellation round

US-based biopharmaceutical company Constellation Pharmaceuticals closed a $55m round of funding on Wednesday backed by SR One, the corporate venturing arm of pharmaceutical firm GlaxoSmithKline. Private equity firm Topspin Partners co-led the round with undisclosed investors, while Third Rock Ventures, Column Group, Venrock and unnamed funds also contributed capital. Founded in 2008, Constellation’s treatments are… Continue reading GSK stars in $55m Constellation round